Published in Ugeskr Laeger on January 09, 2006
Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab (2005) 3.43
Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab (2005) 2.77
Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr (2011) 2.47
Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol (2004) 1.64
A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro. Diabetes (2002) 1.57
Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study. Am J Physiol Endocrinol Metab (2010) 1.46
Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am J Physiol Endocrinol Metab (2003) 1.43
Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution. J Clin Endocrinol Metab (2004) 1.37
Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur J Endocrinol (2003) 1.26
Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. Eur J Endocrinol (2008) 1.26
Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss. Eur J Endocrinol (2007) 1.20
Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol Cell Endocrinol (2002) 1.18
Diet-induced weight loss and exercise alone and in combination enhance the expression of adiponectin receptors in adipose tissue and skeletal muscle, but only diet-induced weight loss enhanced circulating adiponectin. J Clin Endocrinol Metab (2009) 1.15
AICAR stimulates adiponectin and inhibits cytokines in adipose tissue. Biochem Biophys Res Commun (2004) 1.14
Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots. Obesity (Silver Spring) (2006) 1.13
Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels. Am J Physiol Endocrinol Metab (2003) 1.11
Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesis. Circulation (2004) 1.07
Resveratrol in metabolic health: an overview of the current evidence and perspectives. Ann N Y Acad Sci (2013) 1.01
Weight loss maintenance in severely obese adults after an intensive lifestyle intervention: 2- to 4-year follow-up. Obesity (Silver Spring) (2007) 1.01
Evidence of increased visceral obesity and reduced physical fitness in healthy insulin-resistant first-degree relatives of type 2 diabetic patients. Eur J Endocrinol (2004) 0.99
Association between dietary glycemic index, glycemic load, and body mass index in the Inter99 study: is underreporting a problem? Am J Clin Nutr (2006) 0.97
The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss. Obesity (Silver Spring) (2013) 0.96
11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization. Obesity (Silver Spring) (2007) 0.96
Artificial sweeteners: a place in the field of functional foods? Focus on obesity and related metabolic disorders. Curr Opin Clin Nutr Metab Care (2012) 0.95
Comparable reduction of the visceral adipose tissue depot after a diet-induced weight loss with or without aerobic exercise in obese subjects: a 12-week randomized intervention study. Eur J Endocrinol (2009) 0.92
Resveratrol has inhibitory effects on the hypoxia-induced inflammation and angiogenesis in human adipose tissue in vitro. Eur J Pharm Sci (2013) 0.92
[Severe iron-deficiency anaemia after gastric bypass]. Ugeskr Laeger (2014) 0.92
Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment. Clin Endocrinol (Oxf) (2009) 0.92
Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet. Nutr Res (2012) 0.91
Opposite regulation of interleukin-8 and tumor necrosis factor-alpha by weight loss. Obes Res (2002) 0.91
[Hypoglycaemia after gastric bypass is a challenge to diagnostic procedures and treatment]. Ugeskr Laeger (2014) 0.90
Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects. Metabolism (2009) 0.90
The anti-diabetic AMPK activator AICAR reduces IL-6 and IL-8 in human adipose tissue and skeletal muscle cells. Mol Cell Endocrinol (2008) 0.89
Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy. Metabolism (2006) 0.89
Acute exercise increases circulating inflammatory markers in overweight and obese compared with lean subjects. Eur J Appl Physiol (2013) 0.87
Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index--a cross-sectional study. J Pediatr (2004) 0.87
Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue. J Clin Endocrinol Metab (2005) 0.82
Anti-glucocorticoid effects of progesterone in vivo on rat adipose tissue metabolism. Steroids (2003) 0.81
Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy. J Med Virol (2005) 0.80
[Implementation of clinical guidelines in general practice. The effect of journal audit and continuing education for the treatment of cardiovascular risk factors in patients with and without type 2 diabetes]. Ugeskr Laeger (2006) 0.79
Pro- and mature IGF-II during diet-induced weight loss in obese subjects. Eur J Endocrinol (2005) 0.79
Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen. Obesity (Silver Spring) (2008) 0.79
The effect of high-dose vitamin D supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin d: results from a randomized controlled study. Calcif Tissue Int (2013) 0.78
[Prevention of obesity among children and adolescents--proposal for a strategy]. Ugeskr Laeger (2007) 0.78
Circulating sex hormones and gene expression of subcutaneous adipose tissue oestrogen and alpha-adrenergic receptors in HIV-lipodystrophy: implications for fat distribution. Clin Endocrinol (Oxf) (2007) 0.78
[Prevention and treatment of obesity in children]. Ugeskr Laeger (2006) 0.78
Effect of orlistat on eating behavior among participants in a 3-year weight maintenance trial. Obesity (Silver Spring) (2008) 0.78
Ethanol exerts anti-inflammatory effects in human adipose tissue in vitro. Mol Cell Endocrinol (2008) 0.78
[Monitoring the prevalence of obesity]. Ugeskr Laeger (2008) 0.77
Effects on food intake and blood lipids of cannabinoid receptor 1 antagonist treatment in lean rats. Obesity (Silver Spring) (2008) 0.76
Sulfatide increases adiponectin and decreases TNF-alpha, IL-6, and IL-8 in human adipose tissue in vitro. Mol Cell Endocrinol (2006) 0.76
The production and regulation of IGF and IGFBPs in human adipose tissue cultures. Growth Horm IGF Res (2012) 0.76
[Is there an obesity epidemic?]. Ugeskr Laeger (2005) 0.75
[Weight history of patients with newly diagnosed type 2 diabetes--secondary publication]. Ugeskr Laeger (2008) 0.75
[Letigen, insulin resistance and treatment of obesity]. Ugeskr Laeger (2002) 0.75
Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome. J Endocrinol Invest (2014) 0.75
[Is Danish Christmas holiday compatible with healthy life style?]. Ugeskr Laeger (2003) 0.75
[Economic and health: history about trans fatty acids]. Ugeskr Laeger (2004) 0.75
[Letigen, insulin resistance and treatment of obesity--again]. Ugeskr Laeger (2002) 0.75
[Is there a future for medical treatment of obesity?]. Ugeskr Laeger (2009) 0.75
[Severe hypoglycaemia and dumping syndrome after bariatric surgery]. Ugeskr Laeger (2014) 0.75
[Occurrence of obesity: stagnation of the increase]. Ugeskr Laeger (2012) 0.75
[Work-up and treatment of iron deficiency anaemia after bariatric surgery with gastric bypass]. Ugeskr Laeger (2014) 0.75
[The obese patient]. Ugeskr Laeger (2006) 0.75
[Weight changes and the effect of anti-diabetes treatment in the first 5 years after diabetes diagnosis - secondary publication]. Ugeskr Laeger (2006) 0.75
[Physical activity is healthy--dietary supplements ad doping are not]. Ugeskr Laeger (2009) 0.75
[Central fat deposits contribute to atherosclerosis and insulin resistance and peripheral fat deposits protect against atherosclerosis and insulin resistance in postmenopausal women--secondary publication]. Ugeskr Laeger (2005) 0.75
[Measurement of body mass index and waist and hip circumference in adults]. Ugeskr Laeger (2009) 0.75
[Obesity in Denmark--why has it not gone so badly?]. Ugeskr Laeger (2006) 0.75
Intrahepatic fat content correlates with soluble CD163 in relation to weight loss induced by Roux-en-Y gastric bypass. Obesity (Silver Spring) (2014) 0.75
[Monogenetic obesity with special focus on the melanocortin 4 receptor gene mutations]. Ugeskr Laeger (2004) 0.75
Changes in Prescription Drug Use After Gastric Bypass Surgery: A Nationwide Cohort Study. Ann Surg (2017) 0.75
[Rare, severe hypersensitivity reaction to potassium iodide]. Ugeskr Laeger (2014) 0.75
[Surgical treatment of severe obesity. The effect of laparoscopic adjustable gastric banding]. Ugeskr Laeger (2005) 0.75
[Many complications after Roux-en-Y gastric bypass surgery can be prevented and treated]. Ugeskr Laeger (2016) 0.75